NO962231L - Prolegemidler av paclitaxelderivater - Google Patents

Prolegemidler av paclitaxelderivater

Info

Publication number
NO962231L
NO962231L NO962231A NO962231A NO962231L NO 962231 L NO962231 L NO 962231L NO 962231 A NO962231 A NO 962231A NO 962231 A NO962231 A NO 962231A NO 962231 L NO962231 L NO 962231L
Authority
NO
Norway
Prior art keywords
drugs
paclitaxel derivatives
paclitaxel
derivatives
Prior art date
Application number
NO962231A
Other languages
English (en)
Other versions
NO315233B1 (no
NO962231D0 (no
Inventor
Paul M Scola
Dolatrai M Vyas
John F Kadow
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO962231D0 publication Critical patent/NO962231D0/no
Publication of NO962231L publication Critical patent/NO962231L/no
Publication of NO315233B1 publication Critical patent/NO315233B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6551—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a four-membered ring
    • C07F9/65512—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a four-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19962231A 1995-06-06 1996-05-31 Prolegemidler av paclitaxelderivater NO315233B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46924795A 1995-06-06 1995-06-06

Publications (3)

Publication Number Publication Date
NO962231D0 NO962231D0 (no) 1996-05-31
NO962231L true NO962231L (no) 1996-12-09
NO315233B1 NO315233B1 (no) 2003-08-04

Family

ID=23863053

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19962231A NO315233B1 (no) 1995-06-06 1996-05-31 Prolegemidler av paclitaxelderivater

Country Status (23)

Country Link
EP (1) EP0747385B1 (no)
JP (1) JPH08337589A (no)
KR (1) KR100375956B1 (no)
CN (1) CN1066151C (no)
AR (1) AR002756A1 (no)
AT (1) ATE222259T1 (no)
AU (1) AU695959B2 (no)
CA (1) CA2176191A1 (no)
CZ (1) CZ291516B6 (no)
DE (1) DE69622933T2 (no)
DK (1) DK0747385T3 (no)
ES (1) ES2181824T3 (no)
HU (1) HUP9601524A3 (no)
IL (1) IL118526A (no)
MX (1) MX9601994A (no)
NO (1) NO315233B1 (no)
NZ (1) NZ286723A (no)
PL (1) PL187883B1 (no)
PT (1) PT747385E (no)
RU (1) RU2162082C2 (no)
SG (1) SG72692A1 (no)
TW (1) TW354293B (no)
ZA (1) ZA964261B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395770B1 (en) * 1995-10-26 2002-05-28 Baker Norton Pharmaceuticals, Inc. Method and compositions for administering taxanes orally to human patients
US6515016B2 (en) 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
KR100615783B1 (ko) * 1997-05-27 2006-08-25 아이박스 리서치 인코포레이티드 탁산 치료를 받고 있는 인체를 제외한 포유동물의 과민증 또는 알러지 반응을 경감시키기 위한 방법 및 약학적 키트
US6204257B1 (en) 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
WO2000048606A1 (en) * 1999-02-18 2000-08-24 Oxigene, Inc. Compositions and methods for use in targeting vascular destruction
US6362172B2 (en) * 2000-01-20 2002-03-26 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
IL145637A0 (en) 2000-02-02 2002-06-30 Univ Florida State Res Found C7 carbonate substituted taxanes as antitumor agents
CO5280224A1 (es) 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
US6750246B1 (en) 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
US6916942B2 (en) 2000-02-03 2005-07-12 Bristol-Myers Squibb Company Process for the preparation of C-4 carbonate taxanes
US7063977B2 (en) 2001-08-21 2006-06-20 Bristol-Myers Squibb Company Enzymatic resolution of t-butyl taxane derivatives
KR20030049023A (ko) * 2001-12-13 2003-06-25 주식회사 코오롱 방사선 감작제용 파클리탁셀 유도체
KR101016969B1 (ko) * 2001-12-21 2011-02-25 에이자이 아이엔씨. 알콜 및 페놀의 수용성 포스포노옥시메틸 유도체를제조하는 방법
PE20060014A1 (es) 2004-03-05 2006-02-18 Univ Florida State Res Found Taxanos con sustituyentes lactiloxilo en el c7
CN105879114A (zh) * 2005-02-18 2016-08-24 阿布拉西斯生物科学公司 用于整合入医疗装置的疏水性改善的药物
ITMI20050614A1 (it) * 2005-04-12 2006-10-13 Indena Spa Processo per la purificazione della 10-deacetilbaccatina iii dalla 10-deacetil-2-debenzoil-2-pentenoilbaccatina iii
RU2420239C1 (ru) * 2009-10-21 2011-06-10 Федеральное государственное учреждение "Ростовский научно-исследовательский онкологический институт Федерального агентства по высокотехнологичной медицинской помощи" Способ лечения злокачественных забрюшинных опухолей у детей и подростков
US20160024084A1 (en) 2013-03-15 2016-01-28 Concert Pharmaceuticals, Inc. Deuterated palbociclib
WO2015009889A1 (en) 2013-07-18 2015-01-22 Concert Pharmaceuticals, Inc. Deuterated intedanib derivatives and their use for the treatment of proliferative disorders
JP7110094B2 (ja) * 2015-11-19 2022-08-01 バイオヘイブン・ファーマシューティカル・ホールディング・カンパニー・リミテッド 医薬化合物のアミンプロドラッグ

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2017724C1 (ru) * 1990-07-12 1994-08-15 Дзе Юниверсити оф Канзас Способ получения производных таксола
CA2111527C (en) * 1992-12-24 2000-07-18 Jerzy Golik Phosphonooxymethyl ethers of taxane derivatives
CA2129288C (en) * 1993-08-17 2000-05-16 Jerzy Golik Phosphonooxymethyl esters of taxane derivatives

Also Published As

Publication number Publication date
MX9601994A (es) 1997-08-30
SG72692A1 (en) 2000-05-23
JPH08337589A (ja) 1996-12-24
DE69622933D1 (de) 2002-09-19
KR970000222A (ko) 1997-01-21
DE69622933T2 (de) 2003-04-24
IL118526A (en) 2001-05-20
ATE222259T1 (de) 2002-08-15
HUP9601524A3 (en) 2000-03-28
EP0747385A1 (en) 1996-12-11
PT747385E (pt) 2002-11-29
NO315233B1 (no) 2003-08-04
ES2181824T3 (es) 2003-03-01
CN1144805A (zh) 1997-03-12
NZ286723A (en) 1998-03-25
CZ291516B6 (cs) 2003-03-12
IL118526A0 (en) 1996-10-16
AU695959B2 (en) 1998-08-27
HU9601524D0 (en) 1996-07-29
NO962231D0 (no) 1996-05-31
CA2176191A1 (en) 1996-12-07
PL314637A1 (en) 1996-12-09
AR002756A1 (es) 1998-04-29
CZ156396A3 (en) 1996-12-11
DK0747385T3 (da) 2002-12-16
HUP9601524A2 (en) 1997-05-28
TW354293B (en) 1999-03-11
PL187883B1 (pl) 2004-10-29
ZA964261B (en) 1997-11-27
RU2162082C2 (ru) 2001-01-20
CN1066151C (zh) 2001-05-23
EP0747385B1 (en) 2002-08-14
AU5471896A (en) 1996-12-19
KR100375956B1 (ko) 2003-04-21

Similar Documents

Publication Publication Date Title
NO962231L (no) Prolegemidler av paclitaxelderivater
EP0948341A4 (en) DERIVATIVES OF PHOSPHOLIPIDE MEDICINES
NO974466D0 (no) Anvendelse av fumagillol og derivater derav for fremstilling av medikamenter mot tarminfeksjoner
EE9800227A (et) 17ß-karboksü-, karbotio- ja amiidandrostaanide laktoonderivaadid
BR9611130A (pt) Derivados de 3-aril-5-halógeno-pirona
NO995113D0 (no) Substituerte benzopyranderivater for behandling av inflammasjon
DE69629755D1 (de) Irbesartanhaltiges Arzneimittel
FI930491A7 (fi) Fosfono-oxi- och karbonatderivat av taxol
NO20002443L (no) FremgangsmÕte for fremstilling av derivater av taxoidklassen
DE69628353D1 (de) Benzopyran enthaltende Verbindungen und deren Prodrugformen
NO982809D0 (no) Prolegemidler av tombin-inhibitorer
PT858325E (pt) Formulacao farmaceutica liofilizada estavel
NO953244L (no) Derivater av cyklodepeptid PF 1022
NO973938L (no) Farmasöytisk preparat av piperidinoalkanolforbindelser
DE69603269D1 (de) Derivate von inulin
NO20005187D0 (no) n-sats syntese av 2-oksazolidinonderivater
EP0850057A4 (en) Pharmaceutical compounds
NO982237L (no) FremgangsmÕte for fremstilling av fenylimidazolidinderivater
NO973455D0 (no) Dermatologisk anvendelse av Vitamin-D-derivater
FI964619A0 (fi) Epilepsialääkkeiden iholle annostelu
ATE224891T1 (de) Chromon-derivate
BR9607046A (pt) Derivados de 3-pirrolidiliden-2-ona-cefalosporinas
NO981537D0 (no) Fremgangsmåte for fremstilling av antimalariamedikamenter
BR9609723A (pt) Derivados da tricetona
EP0804205A4 (en) 4-AZA-19-NORANDROSTANDERIVATE

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application